Vascular Health and Risk Factors in Children with Down Syndrome
唐氏综合症儿童的血管健康和危险因素
基本信息
- 批准号:10117908
- 负责人:
- 金额:$ 18.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-15 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAgingAtherosclerosisBlood VesselsCancer FamilyCardiovascular DiseasesCardiovascular systemChildChildhoodDataDementiaDevelopment PlansDiagnosisDietDiseaseDown SyndromeEarly treatmentEvaluationFamily history ofFastingFractionationFutureGlucoseHealthHeartHemoglobinHypertensionIndividualInsulinInternationalInterventionIntervention TrialK-Series Research Career ProgramsLeadershipLipidsMeasuresMedialMentorsMorbidity - disease rateMyocardial InfarctionOutcome MeasurePhysiologic pulsePopulationPrevalencePublishingRecording of previous eventsResearchResearch DesignResearch MethodologyResourcesRiskRisk FactorsRisk MarkerSerologicalSleep Apnea SyndromesSmokeThickTrainingUniversitiesUtahVascular Diseasescardiovascular disorder riskcardiovascular risk factorcareer developmentclinical riskcongenital heart disorderepidemiology studyimaging studyimprovedmortalitypredictive modelingpreventprogramsstatistics
项目摘要
ABSTRACT:
Background: The risk of cardiovascular (CV) diseases associated with aging is increasing as individuals with
Down syndrome (DS) are living longer. CV disease risk factors diagnosed in children track into adulthood and
cause dementia and heart attacks. Because many CV disease risk factors are modifiable, however, early
treatment may delay or prevent adult disease. Subclinical changes in vascular health can be measured using
vascular studies, including pulse wave velocity (PWV), carotid intimal medial thickness (CIMT), and carotid
distensibility (CD). Each measure has been associated with future risk of vascular disease. Data in adults with
DS show CV disease risk factor profiles and vascular study results differ compared to results from individuals
without DS. In children with DS, CV disease risk factor data are limited with few studies evaluating the impact
of CV disease risk factors on vascular health. We aim to determine the prevalence of CV disease risk factors in
children with DS and evaluate their effect on vascular markers of early atherosclerosis.
Research Design and Methods: We propose a cross-sectional evaluation of CV disease risk factors and their
impact on vascular health in children with DS to be performed at 3 centers within the Pediatric Heart Network
(PHN). Specific Aim 1: Evaluate CV disease risk factors in children with DS. We will describe common CV
disease risk factors in children with DS including anthropometric measures, clinical risk factors (diet; activity;
smoke exposure; hypertension; history of congenital heart disease, sleep apnea, cancer; and family history of
early CV disease), and serologic risk factors (fasting lipid profiles with sub-fractionation, insulin, glucose,
hemoglobin AIc, and CRP) in children with DS. We will compare these data to published national norms of
children without DS. Specific Aim 2: Determine the associations between CV disease risk factors and markers
of early atherosclerosis in children with DS. We will perform PWV, CIMT, and CD studies in children with DS
and compare these data to available data in children without DS. We will use findings from Specific Aim 1 to
perform multivariable analysis to determine the influence of combinations of vascular disease risk factors
unique to children with DS on their vascular studies.
Career Development Plan: The KL2 Career Development Award will address these gaps in my current
research abilities: 1) improve my understanding and ability to evaluate CV risk factors, prediction models, and
outcome measures including those used in interventional trials; 2) ability to perform and interpret advanced
vascular imaging studies; 3) develop the expertise in study design, statistics, epidemiology, and research
leadership needed to conduct CV studies in children with DS. These weaknesses will be addressed using the
resources provided by the University of Utah's robust KL2 program and through recommended courses and
hands-on training as well as interactions with an international team of mentors and advisors.
抽象的:
背景:随着患有患者的个人,与衰老相关的心血管疾病的风险正在增加
唐氏综合症(DS)的寿命更长。在儿童中诊断为成年的CV疾病危险因素和
引起痴呆和心脏病发作。因为许多CV疾病危险因素都是可修改的,但是,早期
治疗可能会延迟或预防成人疾病。可以使用血管健康的亚临床变化
血管研究,包括脉搏波速度(PWV),颈动脉内膜厚度(CIMT)和颈动脉
扩张性(CD)。每种措施都与未来的血管疾病风险有关。成年人的数据
与个体的结果相比
没有DS。在患有DS的儿童中,CV疾病危险因素数据受到限制,很少有研究评估影响
CV疾病风险因素对血管健康的危险因素。我们旨在确定简历疾病风险因素的流行
患有DS的儿童并评估他们对早期动脉粥样硬化血管标志物的影响。
研究设计和方法:我们提出了对简历疾病风险因素及其的横断面评估
在小儿心脏网络内3个中心进行DS儿童的血管健康的影响
(PHN)。具体目标1:评估DS儿童的简历疾病危险因素。我们将描述常见的简历
DS儿童的疾病风险因素,包括人体测量指标,临床风险因素(饮食;活动;
烟雾暴露;高血压;先天性心脏病的史,睡眠呼吸暂停,癌症;和家族史
早期CV疾病)和血清学危险因素(禁食脂质谱,亚漏液,胰岛素,葡萄糖,
DS儿童中的血红蛋白AIC和CRP)。我们将将这些数据与已发布的国家规范进行比较
没有DS的孩子。特定目的2:确定CV疾病风险因素与标记之间的关联
DS儿童早期动脉粥样硬化。我们将对患有DS的儿童进行PWV,CIMT和CD研究
并将这些数据与无DS儿童的可用数据进行比较。我们将使用特定目标1的调查结果到
进行多变量分析以确定血管疾病风险因素的组合的影响
在其血管研究中具有DS的儿童独有。
职业发展计划:KL2职业发展奖将解决我当前的这些差距
研究能力:1)提高我的理解和评估简历风险因素,预测模型和
结局措施,包括用于介入试验的结果; 2)能够执行和解释高级
血管成像研究; 3)发展研究设计,统计,流行病学和研究方面的专业知识
领导需要对DS儿童进行简历研究。这些弱点将使用
犹他大学强大的KL2计划提供的资源以及推荐的课程和
动手培训以及与国际导师和顾问团队的互动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAUREEN A MURTAUGH其他文献
MAUREEN A MURTAUGH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAUREEN A MURTAUGH', 18)}}的其他基金
CTSA K12 Program at University of Utah: Early Career Faculty Development Program
犹他大学 CTSA K12 项目:早期职业教师发展项目
- 批准号:
10622139 - 财政年份:2023
- 资助金额:
$ 18.23万 - 项目类别:
Nonpharmacological Strategies to Mitigate Pain and Problematic Opioid Use After Spine Surgery
减轻脊柱手术后疼痛和阿片类药物使用问题的非药物策略
- 批准号:
10274904 - 财政年份:2018
- 资助金额:
$ 18.23万 - 项目类别:
Validation of the EARTH Study Diet History Questionnaire
地球研究饮食史问卷的验证
- 批准号:
7141532 - 财政年份:2006
- 资助金额:
$ 18.23万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 18.23万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 18.23万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 18.23万 - 项目类别:
Mitochondrial electron transport dysfunction: Dissecting pathomechanisms
线粒体电子传递功能障碍:剖析病理机制
- 批准号:
10679988 - 财政年份:2023
- 资助金额:
$ 18.23万 - 项目类别: